Phosphorylated MAPK11 promotes the progression of clear cell renal cell carcinoma by maintaining RUNX2 protein

Xiandong Song1, Changming Dong1, Xiaojun Man1

  • 1Department of Urology, The First Hospital of China Medical University, Shenyang, Liaoning, China.

Insights

Mitogen-activated protein kinase 11 (MAPK11) and Runt-associated transcription factor 2 (RUNX2) are overexpressed in clear cell renal cell carcinoma (ccRCC). This P-MAPK11/RUNX2 axis promotes ccRCC progression and may be a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Mitogen-activated protein kinase 11 (MAPK11) is crucial in cell signaling pathways, influencing cell viability, differentiation, proliferation, and apoptosis.
  • While MAPK11 is implicated in various cancers, its specific role in clear cell renal cell carcinoma (ccRCC) remains largely unelucidated.
  • Runt-associated transcription factor 2 (RUNX2) is a key transcription factor in osteoblast and chondrocyte development, with known overexpression in several tumor types.

Purpose of the Study:

  • To investigate the expression and molecular mechanisms of MAPK11 and RUNX2 in clear cell renal cell carcinoma (ccRCC).
  • To determine the functional roles of MAPK11 and RUNX2 in ccRCC cell proliferation and migration.
  • To explore the interaction between MAPK11 and RUNX2 and its impact on ccRCC progression.

Main Methods:

  • Analysis of mRNA and protein levels in ccRCC tissues versus adjacent tissues using The Cancer Genome Atlas (TCGA) database and western blotting.
  • Assessment of ccRCC cell proliferation via colony formation and EdU assays, and cell migration using Transwell assays.
  • Detection of protein interactions via immunoprecipitation and measurement of RUNX2 protein stability using cycloheximide chase assays.

Main Results:

  • Overexpression of both MAPK11 and RUNX2 was observed in ccRCC tissues and cell lines.
  • MAPK11 and RUNX2 significantly promoted ccRCC cell proliferation and migration.
  • A physical interaction between RUNX2 and phosphorylated MAPK11 (P-MAPK11) was identified, stabilizing RUNX2 protein and potentially counteracting MAPK11 degradation.

Conclusions:

  • The P-MAPK11/RUNX2 axis is upregulated in ccRCC and drives tumor progression.
  • The interaction between P-MAPK11 and RUNX2 enhances RUNX2 stability, contributing to ccRCC development.
  • Targeting the P-MAPK11/RUNX2 axis presents a potential therapeutic strategy for ccRCC.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.5K